Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Accounts Payables (2018 - 2025)

Neurogene (NGNE) has disclosed Accounts Payables for 5 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accounts Payables fell 8.31% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, down 8.31%, and an annual FY2024 reading of $1.3 million, changed N/A over the prior year.
  • Accounts Payables was $1.5 million for Q3 2025 at Neurogene, down from $2.1 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $3.1 million in Q1 2025 and bottomed at $1.3 million in Q4 2024.